Carregant...

Heterogeneity at the invasion front of triple negative breast cancer cells

Identifying better predictive and prognostic biomarkers for the diagnosis and treatment of triple negative breast cancer (TNBC) is complicated by tumor heterogeneity ranging from responses to therapy, mutational burden, and clonal evolution. To overcome the gap in our understanding of tumor heteroge...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Aw Yong, Koh Meng, Ulintz, Peter J., Caceres, Sara, Cheng, Xu, Bao, Liwei, Wu, Zhifen, Jiagge, Evelyn M., Merajver, Sofia D.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113246/
https://ncbi.nlm.nih.gov/pubmed/32238832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-62516-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!